Agios Stock Rebounds After Mitapivat Hits Key Target in Thalassemia Trial (NASDAQ:AGIO)
Agios Pharmaceuticals (NASDAQ: AGIO) stocks rose ~33% premarket on Wednesday after a late-stage global trial of mitapivat in adults with ...
Agios Pharmaceuticals (NASDAQ: AGIO) stocks rose ~33% premarket on Wednesday after a late-stage global trial of mitapivat in adults with ...